Literature DB >> 32558186

SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus.

Alexanda K Ling1, Meagan Munro2, Natasha Chaudhary2, Conglei Li1, Maribel Berru1, Brendan Wu1, Daniel Durocher2,3, Alberto Martin1.   

Abstract

The newly identified shieldin complex, composed of SHLD1, SHLD2, SHLD3, and REV7, lies downstream of 53BP1 and acts to inhibit DNA resection and promote NHEJ. Here, we show that Shld2-/- mice have defective class switch recombination (CSR) and that loss of SHLD2 can suppress the embryonic lethality of a Brca1Δ11 mutation, highlighting its role as a key effector of 53BP1. Lymphocyte development and RAG1/2-mediated recombination were unaffected by SHLD2 deficiency. Interestingly, a significant fraction of Shld2-/- primary B-cells and 53BP1- and shieldin-deficient CH12F3-2 B-cells permanently lose expression of immunoglobulin upon induction of CSR; this population of Ig-negative cells is also seen in other NHEJ-deficient cells and to a much lesser extent in WT cells. This loss of Ig is due to recombination coupled with overactive resection and loss of coding exons in the downstream acceptor constant region. Collectively, these data show that SHLD2 is the key effector of 53BP1 and critical for CSR in vivo by suppressing large deletions within the Igh locus.
© 2020 The Authors.

Entities:  

Keywords:  B cell; BRCA1; Shld2−/− mouse; class switch recombination; shieldin

Mesh:

Year:  2020        PMID: 32558186      PMCID: PMC7403657          DOI: 10.15252/embr.201949823

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  40 in total

1.  ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.

Authors:  Andrea L Bredemeyer; Girdhar G Sharma; Ching-Yu Huang; Beth A Helmink; Laura M Walker; Katrina C Khor; Beth Nuskey; Kathleen E Sullivan; Tej K Pandita; Craig H Bassing; Barry P Sleckman
Journal:  Nature       Date:  2006-06-14       Impact factor: 49.962

2.  The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated γH2AX Formation.

Authors:  Shaliny Ramachandran; Dania Haddad; Conglei Li; Michael X Le; Alexanda K Ling; Clare C So; Rajeev M Nepal; Jennifer L Gommerman; Kefei Yu; Troy Ketela; Jason Moffat; Alberto Martin
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

3.  Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching.

Authors:  Michela Di Virgilio; Elsa Callen; Arito Yamane; Wenzhu Zhang; Mila Jankovic; Alexander D Gitlin; Niklas Feldhahn; Wolfgang Resch; Thiago Y Oliveira; Brian T Chait; André Nussenzweig; Rafael Casellas; Davide F Robbiani; Michel C Nussenzweig
Journal:  Science       Date:  2013-01-10       Impact factor: 47.728

4.  53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.

Authors:  Elsa Callen; Dali Zong; Wei Wu; Nancy Wong; Andre Stanlie; Momoko Ishikawa; Raphael Pavani; Lavinia C Dumitrache; Andrea K Byrum; Carlos Mendez-Dorantes; Paula Martinez; Andres Canela; Yaakov Maman; Amanda Day; Michael J Kruhlak; Maria A Blasco; Jeremy M Stark; Nima Mosammaparast; Peter J McKinnon; André Nussenzweig
Journal:  Mol Cell       Date:  2019-10-22       Impact factor: 17.970

5.  Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern.

Authors:  M Wiesendanger; B Kneitz; W Edelmann; M D Scharff
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

6.  MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes.

Authors:  Teresa M Wilson; Alexandra Vaisman; Stella A Martomo; Patsa Sullivan; Li Lan; Fumio Hanaoka; Akira Yasui; Roger Woodgate; Patricia J Gearhart
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307

7.  FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.

Authors:  Junya Tomida; Kei-Ichi Takata; Sarita Bhetawal; Maria D Person; Hsueh-Ping Chao; Dean G Tang; Richard D Wood
Journal:  EMBO J       Date:  2018-05-22       Impact factor: 11.598

8.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

9.  The shieldin complex mediates 53BP1-dependent DNA repair.

Authors:  Sylvie M Noordermeer; Salomé Adam; Dheva Setiaputra; Marco Barazas; Stephen J Pettitt; Alexanda K Ling; Michele Olivieri; Alejandro Álvarez-Quilón; Nathalie Moatti; Michal Zimmermann; Stefano Annunziato; Dragomir B Krastev; Feifei Song; Inger Brandsma; Jessica Frankum; Rachel Brough; Alana Sherker; Sébastien Landry; Rachel K Szilard; Meagan M Munro; Andrea McEwan; Théo Goullet de Rugy; Zhen-Yuan Lin; Traver Hart; Jason Moffat; Anne-Claude Gingras; Alberto Martin; Haico van Attikum; Jos Jonkers; Christopher J Lord; Sven Rottenberg; Daniel Durocher
Journal:  Nature       Date:  2018-07-18       Impact factor: 49.962

10.  53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.

Authors:  Hind Ghezraoui; Catarina Oliveira; Jordan R Becker; Kirstin Bilham; Daniela Moralli; Consuelo Anzilotti; Roman Fischer; Mukta Deobagkar-Lele; Maria Sanchiz-Calvo; Elena Fueyo-Marcos; Sarah Bonham; Benedikt M Kessler; Sven Rottenberg; Richard J Cornall; Catherine M Green; J Ross Chapman
Journal:  Nature       Date:  2018-07-25       Impact factor: 49.962

View more
  8 in total

Review 1.  The molecular basis and disease relevance of non-homologous DNA end joining.

Authors:  Bailin Zhao; Eli Rothenberg; Dale A Ramsden; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-19       Impact factor: 94.444

2.  SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus.

Authors:  Alexanda K Ling; Meagan Munro; Natasha Chaudhary; Conglei Li; Maribel Berru; Brendan Wu; Daniel Durocher; Alberto Martin
Journal:  EMBO Rep       Date:  2020-06-17       Impact factor: 8.807

3.  SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Authors:  Estelle Vincendeau; Wenming Wei; Xuefei Zhang; Cyril Planchais; Wei Yu; Hélène Lenden-Hasse; Thomas Cokelaer; Juliana Pipoli da Fonseca; Hugo Mouquet; David J Adams; Frederick W Alt; Stephen P Jackson; Gabriel Balmus; Chloé Lescale; Ludovic Deriano
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

Review 4.  DNA Damage Response and Repair in Adaptive Immunity.

Authors:  Sha Luo; Ruolin Qiao; Xuefei Zhang
Journal:  Front Cell Dev Biol       Date:  2022-05-17

5.  Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered region.

Authors:  Sandhya Balasubramanian; Matteo Andreani; Júlia Goncalves Andrade; Tannishtha Saha; Devakumar Sundaravinayagam; Javier Garzón; Wenzhu Zhang; Oliver Popp; Shin-Ichiro Hiraga; Ali Rahjouei; Daniel B Rosen; Philipp Mertins; Brian T Chait; Anne D Donaldson; Michela Di Virgilio
Journal:  Elife       Date:  2022-04-13       Impact factor: 8.713

6.  The dystonia gene THAP1 controls DNA double-strand break repair choice.

Authors:  Kenta Shinoda; Dali Zong; Elsa Callen; Wei Wu; Lavinia C Dumitrache; Frida Belinky; Raj Chari; Nancy Wong; Momoko Ishikawa; Andre Stanlie; Trisha Multhaupt-Buell; Nutan Sharma; Laurie Ozelius; Michelle Ehrlich; Peter J McKinnon; André Nussenzweig
Journal:  Mol Cell       Date:  2021-04-14       Impact factor: 19.328

Review 7.  Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.

Authors:  Zu Ye; Yin Shi; Susan P Lees-Miller; John A Tainer
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 8.786

Review 8.  The (Lack of) DNA Double-Strand Break Repair Pathway Choice During V(D)J Recombination.

Authors:  Alice Libri; Timea Marton; Ludovic Deriano
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.